Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
National Hospital Organization Shibukawa Medical Center
Homepage:
shibukawa.hosp.go.jp
Alternate name:
国立病院機構渋川医療センター
Parent institution:
National Hospital Organization
ROR:
00ty7ft53
OpenAlex ID:
I4405283002
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV ‐8‐negative multicentric Castleman disease
2015
·
Noriko Iwaki
, David C. Fajgenbaum
, et al.
·
American Journal of Hematology
·
301
PDF
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
2019
·
Maria-Victoria Mateos
, Hilary Blacklock
, et al.
·
The Lancet Haematology
·
266
PDF
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial
2025
·
Saad Z. Usmani
, Thierry Facon
, et al.
·
Nature Medicine
·
193
PDF
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
2020
·
Meletios A. Dimopoulos
, Sagar Lonial
, et al.
·
Blood Cancer Journal
·
160
PDF
Long non‐coding RNA MALAT 1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma
2017
·
Hiroshi Handa
, Yuko Kuroda
, et al.
·
British Journal of Haematology
·
90
Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation
2017
·
H. Takamatsu
, N. Takezako
, et al.
·
Annals of Oncology
·
52
PDF
A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations
2018
·
Hisao Imai
, Kyoichi Kaira
, et al.
·
Lung Cancer
·
49
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
2020
·
Ou Yamaguchi
, Hisao Imai
, et al.
·
Cancer Chemotherapy and Pharmacology
·
48
A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger
2018
·
Kei Shibuya
, Tatsuya Ohno
, et al.
·
Radiotherapy and Oncology
·
47
The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer
2018
·
Kai Obayashi
, Kimihiro Shimizu
, et al.
·
Journal of Thoracic Disease
·
46
PDF
Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature
2018
·
Nobuhiro Akuzawa
, Masahiko Kurabayashi
·
BMC Cardiovascular Disorders
·
44
PDF
Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
2017
·
Yasushi Goto
, Chiharu Tanai
, et al.
·
ESMO Open
·
41
Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study
2019
·
Takeshi Hatanaka
, Satoru Kakizaki
, et al.
·
Hepatology Research
·
38
Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes
2017
·
M. Tanaka
, H. Yamakage
, et al.
·
Diabetes & Metabolism
·
33
Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study
2019
·
Dai Watanabe
, Tomoko Uehira
, et al.
·
BMC Infectious Diseases
·
32
PDF
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
2019
·
Hisao Imai
, Satoshi Wasamoto
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
31
Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study
2018
·
Kenshi Suzuki
, Meletios A. Dimopoulos
, et al.
·
Blood Cancer Journal
·
31
PDF
Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
2019
·
Jun‐ichi Saitoh
, Katsuyuki Shirai
, et al.
·
Cancer Medicine
·
29
PDF
Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung.
2018
·
Yoichi Ohtaki
, Kyoichi Kaira
, et al.
·
Europe PMC (PubMed Central)
·
28
Staphylococcus aureus ST764-SCCmecII high-risk clone in bloodstream infections revealed through national genomic surveillance integrating clinical data
2025
·
Junzo Hisatsune
, Shoko Kutsuno
, et al.
·
Nature Communications
·
27
A phase 3 randomized study of pembrolizumab (Pembro) plus pomalidomide (Pom) and dexamethasone (Dex) for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-183.
2018
·
Maria-Victoria Mateos
, Hilary Blacklock
, et al.
·
Journal of Clinical Oncology
·
26
Multiple liver abscesses and bacteremia caused by Streptococcus constellatus infection: a case report
2016
·
Nobuhiro Akuzawa
, Takashi Hatori
, et al.
·
Clinical Case Reports
·
25
PDF
A Phase I Study of Hypofractionated Carbon-ion Radiotherapy for Stage III Non-small Cell Lung Cancer
2018
·
JUN-ICHI SAITOH
, KATSUYUKI SHIRAI
, et al.
·
Anticancer Research
·
24
PDF
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
2017
·
Yutaka Tsukune
, Makoto Sasaki
, et al.
·
Blood Cancer Journal
·
24
PDF
Quality control system for mammographic breast positioning using deep learning
2023
·
Haruyuki Watanabe
, Saeko Hayashi
, et al.
·
Scientific Reports
·
23
PDF
Show more works
View as search
Works count:
202
Citation count:
3,985
Year
Topic
Type
